Bank of America Securities has elevated its price target for IBM stock from $315 to $330, maintaining a Buy rating as of July 6. This adjustment signals a projected upside of approximately 14% given IBM's recent trading price of $289.52.
Five-star analyst Wamsi Mohan, who attended the recent Quantum Tech World Conference, labeled IBM as the "quantum leader" in the industry. This designation positions IBM favorably against competitors such as Rigetti, IonQ, D-Wave, Xanadu, and Google's quantum division. Mohan assesses IBM's advancements in quantum technology using three criteria: programmable qubits, operational capabilities, and throughput, which evaluate complexity, reliability, and speed of processing.
IBM's Research Dominance
Between October 2025 and April 2026, IBM produced 781 research papers published on ArXiv, significantly outpacing Google's contribution of 231 papers and Xanadu's 260. This research output underscores IBM's leading role in the quantum computing space.
Anticipations for Q2 Financials
Looking ahead, Bank of America projects that IBM will report Q2 revenues of $18 billion along with earnings per share (EPS) of $3.03 when earnings are released on July 22. The firm also suggests that Confluent could generate $340 million in this quarter, contributing approximately 5% to software growth.
Mohan indicates that the upcoming Q2 report is pivotal and may establish the momentum for the latter half of the year, as improvements are expected in the software mix and transaction processing through the z17 mainframe cycle. Additionally, there are expectations that IBM will revise its full-year 2026 revenue and free cash flow guidance positively.
Long-term Stability and Valuation
With a price-to-earnings (P/E) ratio of 25.48 and a PEG ratio of 0.27, IBM’s stock appears reasonably valued in relation to its growth prospects. Furthermore, the company has maintained a dividend increase for 30 consecutive years, reflecting its commitment to shareholder returns. The consensus view among analysts on TipRanks rates IBM as a Moderate Buy, supported by 12 Buy recommendations and 5 Holds, with an average price target of $302.06, indicating an upside potential of 4.3%.
